The Ensign Group Inc (ENSG):企業の財務・戦略的SWOT分析

◆英語タイトル:The Ensign Group Inc (ENSG) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15515
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:50
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

The Ensign Group Inc (ENSG) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

The Ensign Group Inc (Ensign Group) is a health care company that provides services in the post-acute care continuum and other ancillary businesses. It offers homecare, home health, assisted living, independent living, transitional, hospice, outpatient, rehabilitation, skilled nursing and acute care services. The company offers services through affiliates and facilities in Arizona, California, Kansas, Nebraska, Colorado, Idaho, Iowa, Oregon, South Carolina, Nevada, Oklahoma, Washington, Texas, Utah, Wisconsin and Wyoming. The company is also offers mobile ancillary services and patient transportation. Ensign Group is headquartered in Mission Viejo, California, the US.

The Ensign Group Inc Key Recent Developments

Feb 21,2019 The Ensign Group announces new leadership structure
Feb 06,2019 The Ensign Group reports fourth quarter and fiscal year 2018 results
Aug 02,2018 The Ensign Group reports second quarter results
May 02,2018 The Ensign Group Reports first Quarter Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
The Ensign Group Inc – Key Facts
The Ensign Group Inc – Key Employees
The Ensign Group Inc – Key Employee Biographies
The Ensign Group Inc – Major Products and Services
The Ensign Group Inc – History
The Ensign Group Inc – Company Statement
The Ensign Group Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
The Ensign Group Inc – Business Description
Business Segment: All other
Overview
Performance
Business Segment: Assisted and Independent Living Services
Overview
Performance
Key Stats
Business Segment: Home health and Hospice Services
Overview
Performance
Key Stats
Business Segment: Transitional and Skilled Services
Overview
Performance
Key Stats
The Ensign Group Inc – Corporate Strategy
The Ensign Group Inc – SWOT Analysis
SWOT Analysis – Overview
The Ensign Group Inc – Strengths
The Ensign Group Inc – Weaknesses
The Ensign Group Inc – Opportunities
The Ensign Group Inc – Threats
The Ensign Group Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
The Ensign Group Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
The Ensign Group Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
The Ensign Group Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 21, 2019: The Ensign Group announces new leadership structure
Feb 06, 2019: The Ensign Group reports fourth quarter and fiscal year 2018 results
Aug 02, 2018: The Ensign Group reports second quarter results
May 02, 2018: The Ensign Group Reports first Quarter Results
Feb 08, 2018: The Ensign Group Reports Fourth Quarter and Fiscal Year 2017 Results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
The Ensign Group Inc, Key Facts
The Ensign Group Inc, Key Employees
The Ensign Group Inc, Key Employee Biographies
The Ensign Group Inc, Major Products and Services
The Ensign Group Inc, History
The Ensign Group Inc, Subsidiaries
The Ensign Group Inc, Key Competitors
The Ensign Group Inc, Ratios based on current share price
The Ensign Group Inc, Annual Ratios
The Ensign Group Inc, Annual Ratios (Cont...1)
The Ensign Group Inc, Annual Ratios (Cont...2)
The Ensign Group Inc, Interim Ratios
The Ensign Group Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
The Ensign Group Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
The Ensign Group Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
The Ensign Group Inc, Performance Chart (2014 - 2018)
The Ensign Group Inc, Ratio Charts
The Ensign Group Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
The Ensign Group Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[The Ensign Group Inc (ENSG):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Norfolk Southern Corporation:企業の戦略・SWOT・財務分析
    Norfolk Southern Corporation - Strategy, SWOT and Corporate Finance Report Summary Norfolk Southern Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Evofem Inc-製薬・医療分野:企業M&A・提携分析
    Summary Evofem Inc (Evofem) is a healthcare solution provider that discovers, develops and commercializes prescription and consumer products. The company’s product pipeline includes amphora and nestorone. Evofem improves reproductive health and wellness options for women. It develops products for co …
  • Tactile Systems Technology Inc (TCMD):医療機器:M&Aディール及び事業提携情報
    Summary Tactile Systems Technology Inc (Tactile Medical) is a medical technology company that develops, manufactures and distributes medical devices for the treatment of chronic vascular diseases in a home setting. The company’s products are based on a unique, scalable platform. It offers products f …
  • Nanolek:製薬・医療:M&Aディール及び事業提携情報
    Summary Nanolek is a drug development company that offers production of import-substituting and novel pharmaceuticals. The company’s product portfolio includes vaccines, drugs for treatment of leukemias, breast cancer, brain cancer, stomach and ovarian cancer, colorectal cancer, HIV infection and ot …
  • Crescita Therapeutics Inc (CTX)-製薬・医療分野:企業M&A・提携分析
    Summary Crescita Therapeutics Inc (Crescita Therapeutics) develops products for the treatment of skin diseases and their symptoms. The company’s product portfolio includes over-the-counter and prescription products such as topical creams. It offers pliaglis, a local anesthetic cream for superficial …
  • Response Biomedical Corp-医療機器分野:企業M&A・提携分析
    Summary Response Biomedical Corp (Response Biomedical) focuses on the research, development, manufacture and marketing of diagnostic technologies for the point-of-care (POC), central-lab testing and on-site environmental testing markets. It offers Cardiovascular tests such as Troponin-I, Myoglobin, …
  • Cooperativa Muratori & Cementisti C.M.C di Ravenna:企業の戦略・SWOT・財務分析
    Cooperativa Muratori & Cementisti C.M.C di Ravenna - Strategy, SWOT and Corporate Finance Report Summary Cooperativa Muratori & Cementisti C.M.C di Ravenna - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's struct …
  • Umicore SA:企業の戦略・SWOT・財務情報
    Umicore SA - Strategy, SWOT and Corporate Finance Report Summary Umicore SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Minnkota Power Cooperative Inc:企業の発電所・SWOT分析2018
    Minnkota Power Cooperative Inc - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on ke …
  • Meritz Fire & Marine Insurance Co., Ltd.:企業の戦略・SWOT・財務分析
    Meritz Fire & Marine Insurance Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Meritz Fire & Marine Insurance Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Fidelity National Financial Inc:企業の戦略・SWOT・財務情報
    Fidelity National Financial Inc - Strategy, SWOT and Corporate Finance Report Summary Fidelity National Financial Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Arabian Drilling Co:石油・ガス:M&Aディール及び事業提携情報
    Summary Arabian Drilling Co (ADC) is an oil and gas company that operates land rigs and offshore jack-up rigs. The company provides land and offshore drilling activities. It offers services such as providing drilling units on land and offshore, providing drilling services to find oil and gas efficie …
  • Naturgy Energy Group SA:企業の戦略・SWOT・財務分析
    Naturgy Energy Group SA - Strategy, SWOT and Corporate Finance Report Summary Naturgy Energy Group SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • GAIL (India) Ltd (GAIL)-石油・ガス分野:企業M&A・提携分析
    Summary GAIL (India) Ltd (GAIL) is a vertically integrated gas company that carries out exploration and production, transmission of natural gas. It also has presence in petrochemical, liquid hydrocarbons and power and renewable sectors. GAIL is also a major LPG transmission company, besides managing …
  • Evgen Pharma Plc (EVG):企業の財務・戦略的SWOT分析
    Summary Evgen Pharma Plc (Evgen Pharma), formerly Evgen Pharma Ltd is a clinical-stage drug development company. It is focused on the development of sulforaphane-based compounds for the treatment of cancer and neurological disease. Its pipeline product SFX-01 targets STAT3 signalling to inhibit stem …
  • Pfizer Japan Inc-製薬・医療分野:企業M&A・提携分析
    Summary Pfizer Japan Inc (Pfizer Japan), a subsidiary of Pfizer Inc is a drug company that manufactures, sells, imports and exports prescription drugs. The company’s products include axitinib, crizotinib, sunitinib malate, epirubicin hydrochloride, levofolinate calcium, clindamycin phosphate ester, …
  • Campofrio Food Group, S.A.:企業の戦略・SWOT・財務情報
    Campofrio Food Group, S.A. - Strategy, SWOT and Corporate Finance Report Summary Campofrio Food Group, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Falck Renewables SpA (FKR)
    Falck Renewables SpA (FKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Unum Group:戦略・SWOT・企業財務分析
    Unum Group - Strategy, SWOT and Corporate Finance Report Summary Unum Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • SynCore Biotechnology Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary SynCore Biotechnology Co Ltd (SynCore), a subsidiary of Sinphar Pharmaceutical Co Ltd is a biopharmaceutial company that utilizes and in-licenses technologies to develop new drugs. The company’s pipeline products include SB01, SB02, SB03, SB04 and SB05. Its SB01 drug is a new chemical entity …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆